Deutsche Bank’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238K | Buy |
43,437
+5,811
| +15% | +$31.8K | ﹤0.01% | 2854 |
|
|
2025
Q1 | $237K | Buy |
37,626
+8,383
| +29% | +$52.7K | ﹤0.01% | 2852 |
|
|
2024
Q4 | $120K | Buy |
29,243
+685
| +2% | +$2.82K | ﹤0.01% | 3203 |
|
|
2024
Q3 | $95.4K | Buy |
28,558
+14,635
| +105% | +$48.9K | ﹤0.01% | 3188 |
|
|
2024
Q2 | $41.5K | Sell |
13,923
-3,894
| -22% | -$11.6K | ﹤0.01% | 3313 |
|
|
2024
Q1 | $61.5K | Buy |
+17,817
| New | +$61.5K | ﹤0.01% | 3299 |
|
|
2023
Q4 | – | Sell |
-25,070
| Closed | -$54.7K | – | 3629 |
|
|
2023
Q3 | $54.7K | Buy |
+25,070
| New | +$54.7K | ﹤0.01% | 3360 |
|